In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
Kiwi company turns kiwi waste into leather
In New Zealand, a startup called KiwiLeather Innovations is building a business converting rejected kiwifruit into a leather alternative.
According to Fresh Plaza, over...
UPSIDE Foods serves cultivated chicken at Indy 500 ahead of state ban
In Indiana, UPSIDE Foods served cultivated chicken sandwiches during the recent Indianapolis 500 as it called the state’s upcoming ban on such products “un-American.”...
Bee-free honey maker MeliBio acquired by FoodYoung Labs
In California, MeliBio, a pioneer in bee-free food, has been acquired by Switzerland-based foodtech FoodYoung Labs for an undisclosed sum.
MeliBio has earned global...